The Leeper laboratory studies the vascular biology of atherosclerosis and aneurysm disease. We are interested in the molecular mechanisms that mediate vascular disease, and developing new translational therapies directed against them. Our group uses a combination of hypothesis-free genetic approaches, favoring the concept that insights generated in this manner are likely to have relevance to human disease. Currently, our major focus is on a process known as ‘programmed cell removal’, or ‘efferocytosis’ (Latin: to carry the dead to the grave’). We seek to determine why diseased cells accumulate in the atherosclerotic plaque, and how to harness the power of the immune system as a means to reactivate their removal and stabilize the vulnerable lesion. Our group pursues the goal of true ‘bench-to-bedside’ translation, bringing together interdisciplinary experts spanning the fields of genomics, molecular biology, translational vascular biology, and clinical Vascular Medicine. Ultimately, we seek to train the next generation of investigators and physician-scientists who will develop a platform of new therapies directed against atherosclerosis, which is now the leading killer worldwide.
"Good vascular health is the key to longevity"
Watch Elsie Ross, MD Vascular Surgeon and Eri Fukaya, MD Vascular Medicine Specialist, discuss the importance of vascular health and how to protect your vascular system.
News, Events, and Team Milestones
Publication in Nature Nanotechnology
Trojan horse nanoparticles deliver anti-atherosclerotic therapy specifically to the diseased blood vessel
2023 Young Author Achievement Award
Congrats to Caitlin Bell, MD for receiving the 2023 Young Author Achievement Award for her manuscript "Risk of Cancer After Diagnosis of Cardiovascular Disease". Dr. Bell will be awarded at the 2024 American College of Cardiology Scientific Sessions in Atlanta, GA.
2023 Leeper Lab Holiday Party
Great times at the annual Leeper Lab Christmas party!
2024 VESS Resident Research award
Congrats to Sabina Sorondo, MD for receiving the 2024 VESS Resident Research Award from the Vascular and Endovascular Surgery Society for her project entitled “Assessing Soluble Guanylate Cyclase Stimulators in PAD”.